Treatment of Local Disease in Testicular Cancer
The primary treatment of local disease in testicular cancer has hardly changed during the last 100 years. High inguinal orchiectomy still represents the standard of care. The histological results of the operation together with the staging analysis and tumor markers form the basis for the further adjuvant treatment of testicular cancer. The implementation of a biopsy of the contralateral testis at the time of inguinal orchiectomy for the diagnosis or exclusion of germ cell neoplasia in situ (GCNIS) still remains controversial. In specific conditions such as synchronous and metachronous testicular cancer or a solitary testis, testis-sparing surgery followed by radiation therapy has gained wide acceptance. At the time of inguinal orchiectomy, the implantation of a testicular prosthesis can be offered safely to the patient.
- Dieckmann K-P, Anheuser P, Schmidt S, Soyka-Hundt B, Pichlmeier U, Schriefer P, Matthies C, Hartmann M, Ruf CG. Testicular prostheses in patients with testicular cancer – acceptance rate and patient satisfaction. BMC Urol. 2015;15Google Scholar
- Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, Hamilton W, Hendry A, Hendry M, Lewis R, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92–S107.CrossRefPubMedPubMedCentralGoogle Scholar